Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

European Surgical Research

Clinical and Experimental Surgery

Guidelines for Authors

Disclosure Statement
Plagiarism Policy
Color Illustrations
Digital Object Identifier (DOI)
Supplementary Material
Page Charges
Self-Archiving/Green Open Access, Author's ChoiceTM,
   Funding Organizations (NIH etc.)


Aims and Scope

The prime mission of European Surgical Research is to publish high-quality original manuscripts of basic and translational research and review articles concerned with laboratory and clinical investigations which are relevant to surgical practice and of general interest to a broad range of academic surgeons and surgical researchers. Manuscripts dealing with research relevance to human surgical diseases are given high priority along with those which explore the pathogenesis, etiology, and mechanisms of disease processes. European Surgical Research seeks to preferentially publish research articles that integrate molecular biological methods, along with functional studies, into the analysis of biological questions and that advance basic and translational knowledge of surgical pathophysiology. European Surgical Research will provide an international platform for basic and translational research and clinical investigations impacting directly on surgical care and management. European Surgical Research also features special articles relating to educational, research, or social issues of interest to the academic surgical community.


Only original papers written in English are considered and should be submitted online.

All manuscripts must be accompanied by a cover letter and copyright signed by all authors. Assurance should be given in the cover letter that the manuscript is not under simultaneous consideration by any other publication.

Authors may suggest up to five referees who have expert knowledge on the subject. Suggested referees should not be from the same institution, not have published with the authors during the last 5 years, and should not be prejudiced.

Manuscripts may be submitted to the following sections:

(1) Original Papers on basic, translational and clinical science.
(2) Technical Notes
(3) Reviews

Original Papers: These manuscripts should represent original research in basic, translational, or clinical science. Consideration for publication is based on originality, novelty, scientific soundness, and appropriate analysis. European Surgical Research encourages the submission of relevant and well-conducted work in basic, experimental, and clinical science. Manuscripts should be prepared according to the guidelines for original papers.

Technical Notes: These manuscripts present a new method, experimental model, test procedure, tool, or algorithm that is relevant for surgical research and significantly advances current available knowledge.

Reviews in which a specific field is reviewed through an exhaustive literature survey. An Abstract is required and should be divided into Background, Summary and Key Messages. Review Articles should consist of a maximum of 4,000 words. European Surgical Research aims to publish expert basic and translational reviews of selected up-to-date topics in experimental surgery. On occasion, the Editor-in-Chief will invite additional clinical or basic science reviews on a specific topic, which are usually presented pair-wise. Exceptions include formal true Systematic Reviews with Meta-Analyses which are well performed, and which are considered Original Papers.

Should you experience any problems with your submission, please contact:

Angela Lorenz
Editorial Office ‘European Surgical Research’
S. Karger AG
P.O. Box
CH–4009 Basel (Switzerland)
Tel. +41 61 306 1358
Fax +41 61 306 1434


All manuscripts are subject to editorial review.

Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other journal. Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of European Surgical Research and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

It is the author’s responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.

Disclosure Statement

Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Disclosure statements will be published at the end of the text of the article.

Plagiarism Policy

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.
If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).


Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.

Authors are required to declare the approval codes obtained from the corresponding ethical committee on human and/or animal research.


The manuscript should conform to the following order: title page, abstract and keywords, body, acknowledgments, references, figure legends, tables and figures. Manuscripts should be written in high-quality English suitable for effective communication to a professional medical audience. Authors who are not native speakers of English sometimes receive negative comments from referees or editors about the English-language usage in their manuscripts, and these problems can contribute to the decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors (i) to have their manuscript reviewed for clarity by a colleague whose native language is English and/or (ii) to use one of the many English language editing services that are available via the Web.

All pages, including the figure legends, should be numbered in sequence, and the first author’s name should appear at the upper right corner of each page. Papers not conforming to the journal style will be returned without review.

Title page: The first page of each paper should indicate a concise title of no more than 150 characters, all authors’ names (first name and surname), authors’ institutional affiliations, and a short title for use as running head.

Corresponding author: The exact postal address of author(s) to whom correspondence, proofs, and reprint requests should be sent, including the postal code, must be given at the bottom of the title page. Please also supply phone and number and e-mail address.

Abstract of Reviews: Should be divided into the following subsections: Background, Summary and Key Messages. The Background should provide a brief clinical context for the review and is followed by the Summary, which should include a concise description of the main topics covered in the text. The Key Messages encapsulate the main conclusions of the review.

Abstract of Original Papers and Technical Notes: Submit the abstract on a separate page. The abstract is structured into Background/Purpose, Methods, Results and Conclusions and should be less than 400 words in length.

Key words: Following the abstract, an alphabetical list of five key words that reflect the content of the paper should be given.

Footnotes: Avoid footnotes.

Body of manuscript: The text should be organized into: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, including grant numbers and sources of support, Disclosure/Duality of Interest (optional), and References. Abbreviations/acronyms are defined in both the abstract and body of the text as follows: vascular permeability factor (VPF); transforming growth factor-β (TGF-β). They should only be used in the abstract if they appear twice after being first-mentioned and in the body of the text only if they appear three times after being first-mentioned.

Tables and illustrations: Tables and illustrations (both numbered in sequential Arabic numerals) should be prepared as separate files. Tables require a brief and concise heading. Figures require a legend, prepared as a separate page, after References. Please use scale markers for electron micrographs, and indicate the type of stain used.
For the reproduction of illustrations, only good drawings and original photographs can be accepted; negatives or photocopies cannot be used. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 × 223 mm) or provide crop marks. Electronically submitted b/w half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi.

Color Illustrations

Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are reproduced in black and white. Please avoid referring to the colors in the text and figure legends.

Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page.


In the text identify references by Arabic numerals [in square brackets]. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and not be included in the reference list. The list of references should include only those publications which are cited in the text. Do not alphabetize; number references in the order in which they are first mentioned in the text. The surnames of the authors followed by initials should be given. There should be no punctuation other than a comma to separate the authors. Preferably, please cite all authors. Abbreviate journal names according to the Index Medicus system. Also see International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals (www.icmje.org).


(a) Papers published in periodicals:
Chatel J-M, Bernard H, Orson FM: Isolation and characterization of two complete Ara h 2 isoforms cDNA. Int Arch Allergy Immunol 2003;131:14–18.

(b) Papers published only with DOI numbers:
Theoharides TC, Boucher W, Spear K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol DOI: 10.1159/000063858.

(c) Monographs:
Matthews DE, Fare-well VT: Using and Understanding Medical Statistics, ed 3, revised. Basel, Karger, 1996.

(d) Edited books:
DuBois RN: Cyclooxygenase-2 and colorectal cancer; in Dannenberg AJ, Dubois RN (eds): COX-2. Prog Exp Tum Res. Basel, Karger, 2003, vol 37, pp 124–137.

Reference Management Software: Use of EndNote is recommended for easy management and formatting of citations and reference lists

Digital Object Identifier (DOI)

S. Karger Publishers supports DOIs as unique identifiers for articles. A DOI number will be printed on the title page of each article. DOIs can be useful in the future for identifying and citing articles published online without volume or issue information. More information can be found at www.doi.org

Supplementary Material

Multimedia files and other supplementary files, directly relevant but not essential to the conclusions of a paper, enhance the online version of a publication and increase its visibility on the web. These files will undergo editorial review. The Editors reserve the right to limit the scope and length of the supplementary material. Multimedia and supplementary material should meet production quality standards for publication without the need for any modification or editing. Files should not exceed 10 MB in size. Figures and tables need to have titles and legends, and all files should be supplied separately and labeled clearly. All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material and it will be hosted online at https://karger.figshare.com under a CC BY license. Authors will be charged a processing fee of CHF 250.00 for supplementary material.

Page Charges

A charge of CHF 125.00 per page will be levied for the first 4 printed pages of an article. Any additional page will be charged to the author at CHF 325.00. The allotted size of a paper is equal to approx. 12 manuscript pages (including tables, illustrations and references).

Self-Archiving/Green Open Access

Karger permits authors to archive their pre-prints (i.e. pre-peer review) or post-prints (i.e. accepted manuscript after peer review but before production) on their personal or their institution’s internal website. In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g. ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:

  • Be used for noncommercial purposes only
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g. Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Manuscripts to be archived in PubMed Central due to funding requirements will be submitted by Karger on the author’s behalf [see Funding Organizations (NIH etc.)].

For self-archiving Author's ChoiceTM (Gold Open Access) articles, see Author's ChoiceTM.

Author's ChoiceTM

Karger’s Author's ChoiceTM service broadens the reach of your article and gives all users worldwide free and full access for reading, downloading and printing at www.karger.com. The option is available for a one-time fee of CHF 3,000.00, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license. Reposted Open Access articles must:

  • Follow the terms of the relevant Creative Commons license
  • Be linked to the final version on www.karger.com
  • Include the following statement:

‘The final, published version of this article is available at http://www.karger.com/?doi=[insert DOI number].’

It is the author’s responsibility to fulfill these requirements.

For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article.

Funding Organizations (NIH etc.)

The U.S. National Institutes of Health (NIH) Public Access Policy mandates that accepted, peer-reviewed manuscripts are archived in its digital database, PubMed Central (PMC), within 12 months of the official publication date. As a service to authors, Karger submits NIH-funded articles to PMC on behalf of the authors immediately upon publication. The NIH assigns a PMCID within approximately 1 month and the manuscript will appear in PMC after a 12-month embargo. For authors making their paper Open Access through Author's ChoiceTM, the embargo will be overridden, thereby accelerating the accessibility of the article. Karger also complies with other funders’ requirements (including Wellcome Trust and RCUK) for submission to PMC.
Authors should include information on their grant in the Acknowledgements section of their papers.


Unless indicated otherwise, proofs are sent to the corresponding author and should be returned with the least possible delay. Alterations made in proofs other than the correction of printer's errors are charged to the author.


Order forms and a price list are sent with the proofs. Orders submitted after the issue is printed are subject to considerably higher prices.